Comprehensive buy-side due diligence supports an international buy-and-build strategy

Baker Tilly successfully provided comprehensive due diligence services to Balda in its acquisition of the C. Brewer Company (C. Brewer Co.). Baker Tilly’s services included commercial, financial, operational, and tax due diligence. The purchase is part of Balda’s buy-and-build strategy for the medical segment.

Balda, a listed company in Germany, is a producer of high-quality plastics solutions for the medical technology and electronics markets. Balda provides superior engineering services and products of the highest quality. They have a reputation for a fast, flexible, and tailored approach for its customers. The Balda Medical segment in Bad Oeynhausen, Germany, develops and produces high-quality plastics solutions for the medical technology, pharmaceutical, and diagnostics markets.

C. Brewer Co., headquartered in Anaheim, Cal., specializes in precision injection-molded plastics and associated molds. C. Brewer Co. develops and manufactures high-quality plastic products for the medical and electronics industries.

"The Baker Tilly team was an invaluable component of the C. Brewer acquisition process. Their integrated quality of earnings, commercial, operational, and tax due diligence were able to identify and highlight significant transaction and integration issues early enough in the process for us to adopt our negotiation strategy and integration plans accordingly."

– Vincent Muir, General Manager, Balda